Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.35
Delayed Data
As of 3:59pm ET
 +0.15 / +1.06%
Today’s Change
10.75
Today|||52-Week Range
19.90
-4.65%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 14.50, with a high estimate of 19.00 and a low estimate of 10.00. The median estimate represents a +1.05% increase from the last price of 14.35.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.37
Sales
$30.4M
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.18%
 
 
 
 
 
 
Growthannually -295.69%
 
 
 
 
 
 

Sales

Growthquarterly 28.99%
 
 
 
 
 
 
Growthannually 30.02%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.